For the readers interested in the stock health of iTeos Therapeutics Inc. (ITOS). It is currently valued at $18.00. When the transactions were called off in the previous session, Stock hit the highs of $21.085, after setting-off with the price of $20.00. Company’s stock value dipped to $16.94 during the trading on the day. When the trading was stopped its value was $25.63.Recently in News on April 8, 2022, iTeos Presents New Data for Anti-TIGIT Antibody, EOS-448/GSK4428859A, at the AACR Annual Meeting 2022. Treatment with EOS-448 results in a decrease of TIGIT-positive cells in tumor biopsies, the first evidence of a treatment effect in the tumors of patients treated with an anti-TIGIT antibody. You can read further details here
iTeos Therapeutics Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $52.43 on 01/03/22, with the lowest value was $16.94 for the same time period, recorded on 05/11/22.
iTeos Therapeutics Inc. (ITOS) full year performance was -20.21%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, iTeos Therapeutics Inc. shares are logging -65.67% during the 52-week period from high price, and 3.27% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $17.43 and $52.43.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 2202764 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the iTeos Therapeutics Inc. (ITOS) recorded performance in the market was -61.34%, having the revenues showcasing -50.79% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 659.16M, as it employees total of 94 workers.
Analysts verdict on iTeos Therapeutics Inc. (ITOS)
During the last month, 0 analysts gave the iTeos Therapeutics Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 35.46, with a change in the price was noted -21.55. In a similar fashion, iTeos Therapeutics Inc. posted a movement of -54.49% for the period of last 100 days, recording 505,358 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for ITOS is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
iTeos Therapeutics Inc. (ITOS): Technical Analysis
Raw Stochastic average of iTeos Therapeutics Inc. in the period of last 50 days is set at 5.22%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 6.08%. In the last 20 days, the company’s Stochastic %K was 11.32% and its Stochastic %D was recorded 8.42%.
Let’s take a glance in the erstwhile performances of iTeos Therapeutics Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -61.34%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -38.61%, alongside a downfall of -20.21% for the period of the last 12 months. The shares increased approximately by -35.55% in the 7-day charts and went up by -47.01% in the period of the last 30 days. Common stock shares were lifted by -50.79% during last recorded quarter.